Copertina

Pharmaceutical company payments to Japanese breast cancer practice guideline authors

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Anju Murayama, Kenichi Higuchi, Keerthana R. Byreddy, Kugo Hinari, Yuki Senoo
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Clinical and Translational Discovery
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Financial conflicts of interest in Japanese obstetrics and gynaecology clinical practice guidelines
di: Anju Murayama, et al.
Pubblicazione: (2024)

Financial relationships between board‐certified neurologists and the pharmaceutical industry in Japan
di: Anju Murayama, et al.
Pubblicazione: (2024)

Pharmaceutical industry payments to authors of neurology clinical practice guidelines in Japan: A cross‐sectional study
di: Anju Murayama, et al.
Pubblicazione: (2024)

Nanomedicine: a frontier of the breast cancer treatment
di: Swarup Sonar, et al.
Pubblicazione: (2024)

Targeting autophagy: A promising approach for the treatment of breast cancer brain metastases
di: Steffan T. Nawrocki, et al.
Pubblicazione: (2024)

Toward precision oncology: An integrative multi‐omics approach for prognosis prediction and inferred immunotherapy responsiveness in breast cancer
di: Houda Bendani, et al.
Pubblicazione: (2026)

Unveiling a novel cellular stress response mechanism to photodamage
di: Naibedya Dutta, et al.
Pubblicazione: (2024)

Spatial omics accelerate the study of cancer‐associated fibroblasts in non‐small lung cancer
di: Haozhen Liu, et al.
Pubblicazione: (2024)

Tumor and cancer stem cells‐derived exosomes interplay: A secret of cancer complications
di: Swarup Sonar, et al.
Pubblicazione: (2024)

Exploring new frontiers in lung cancer treatment: The role of cancer‐associated fibroblasts (CAFs) and EGFR‐TKI resistance
di: Jiaqi Liang, et al.
Pubblicazione: (2025)

Clinical signature of exosomal tetraspanin proteins in cancer
di: Asmit Das, et al.
Pubblicazione: (2024)

The prospective trajectory of exosomes‐based cancer nanomedicine
di: Divya Mirgh, et al.
Pubblicazione: (2024)

Investigating the biological effects of socioeconomic adversity in cancer
di: David Füller
Pubblicazione: (2024)

Milk exosomes: Harnessing nature's duality for cancer therapy
di: Asmit Das, et al.
Pubblicazione: (2024)

Clinical trial status of exosomes‐based cancer theranostics
di: Swarup Sonar
Pubblicazione: (2024)

Engineered cell versus modified exosomes in cancer therapy
di: Rajib Dhar, et al.
Pubblicazione: (2024)

Signature of click chemistry in exosome modification for cancer therapeutic
di: Nobendu Mukerjee, et al.
Pubblicazione: (2024)

Plant exosomes: A natural medicine for oral cancer
di: Sidhanti Nyahatkar, et al.
Pubblicazione: (2024)

Role of DNA methylation in cancer development and its clinical applications
di: Swarup Sonar, et al.
Pubblicazione: (2024)

Modified plant‐derived exosomes: Precision medicine in cancer treatment
di: Swastika Maitra, et al.
Pubblicazione: (2024)

Intravital microscopy contribution to cancer: From preclinical to human studies
di: Diogo Moniz‐Garcia, et al.
Pubblicazione: (2025)

Tracking down metabolic vulnerabilities in CDK12‐mutant prostate cancer
di: Wei‐Ling Tu, et al.
Pubblicazione: (2024)

Effects of microRNA on the growth and targeted therapy response on lung cancer
di: Mengchen Zhu, et al.
Pubblicazione: (2024)

Liquid biopsy—A biomarker‐based revolutionising technique in cancer therapy
di: Subham Sarkar, et al.
Pubblicazione: (2024)

Sweat exosomes: A new cutting edge nanomedicine in cancer treatment
di: Bikram Dhara, et al.
Pubblicazione: (2024)

Targeting CD70 in cancer: Mechanisms of immune escape and translational opportunities
di: Akash Sabarwal, et al.
Pubblicazione: (2025)

Translation products of circular RNAs and their functions and application prospects in colorectal cancer
di: Fengsen Wang, et al.
Pubblicazione: (2026)

Translational values of tissue‐resident memory T cells in chronic inflammation and cancer
di: Wanxin Duan, et al.
Pubblicazione: (2025)

Cell‐free DNA‐associated multi‐feature applications in cancer diagnosis and treatment
di: Xiaolu Zhang, et al.
Pubblicazione: (2024)

Clinical and translational research on cancer of the stomach and gastroesophageal junction: A pathologist's view
di: Christoph Röcken
Pubblicazione: (2024)

Sticky situation, strategic strike: Targeting neutrophil extracellular trap‐work in cancer
di: Bo Cao, et al.
Pubblicazione: (2025)

Bacterial surface derived extracellular vesicles: A ground‐breaking approach in cancer therapy
di: Asmit Das, et al.
Pubblicazione: (2024)

Established a therapeutic response prediction model in metastatic gastric cancer by liquid biopsy
di: Sheng Liu, et al.
Pubblicazione: (2024)

Host–microbiota interaction during cancer progression from bulk to single‐cell level
di: Yong‐Jing Ma, et al.
Pubblicazione: (2024)

Molecular mechanisms of ageing in cancer development and therapeutic response: Translational implications for precision oncology
di: Laiba Husain
Pubblicazione: (2025)

Single‐cell sequencing for cancer precision medicine: From mechanism discovery to diagnosis and therapeutics
di: Yue Zhao, et al.
Pubblicazione: (2026)

Plant‐derived exosomes: A new frontier in nano‐medicine for cancer and microbial infection therapy
di: Swastika Maitra, et al.
Pubblicazione: (2024)

Epigenetic dynamics in gastric cancer precancerous lesions: From molecular mechanisms to precision risk stratification
di: Kewei Ma, et al.
Pubblicazione: (2025)

INTEGRAL‐ILCCO cohort data analysis revealed the association of clonal haematopoiesis with an increased risk of lung cancer
di: Chao Cheng, et al.
Pubblicazione: (2024)

Precision treatment paradigm: Genomic features and therapeutic implications in mesenchymal‐epithelial transition‐amplified gastric cancer
di: Yiyi Yu, et al.
Pubblicazione: (2024)